Reducing Colorectal Cancer Death Through Mailed Outreach Screening
This trial is active, not recruiting.
|Treatments||mailed-fit, screening invitation-reminder|
|Sponsor||Corporal Michael J. Crescenz VA Medical Center|
|Collaborator||University of Pennsylvania|
|Start date||October 2015|
|End date||December 2016|
|Trial size||783 participants|
|Trial identifier||NCT02584998, PPO 14-369-2 -- 01522|
The main study aim is to develop, implement and disseminate a pilot population-based mailed FIT outreach screening program in the Philadelphia VA Medical Center that does not rely on having an office visit, by conducting a proof-of-concept 3-arm parallel-design pragmatic randomized trial to (1) Compare the effects of usual care (UC), screening invitation + reminder (invitation-reminder), or screening invitation + mailed FIT kit + reminder (mailed-FIT); (2) Explore whether the FIT completion rate varies by age or race/ethnicity; and (3) Explore barriers to use of mailed outreach screening for veterans.
|Intervention model||parallel assignment|
The completion rate of FIT within 6 months of the mailing of the screening invitation. Absence of screening completion data in the VA medical record system will be recorded as failure to complete screening.
time frame: 6 months
The receipt of any colorectal cancer screening test in the 6-month period after enrollment into the study.
time frame: 6 months
Male or female participants from 50 years up to 74 years old.
Inclusion Criteria: The pragmatic trial will include veterans in southeastern Pennsylvania and Southern New Jersey who, during the funding year, are 50 to 75 years old, have received care at the Philadelphia VA Medical Center in the 18-48 months prior to selection for the study but who have not been seen by primary care in the past 18 months prior to selection, are due for screening, and are asymptomatic for CRC. This includes the period during which 3-sample testing was being regularly used at the Philadelphia VA Medical Center. Exclusion Criteria: Have any known gastrointestinal symptoms such as bleeding, unexplained weight loss, or change in bowel habits, family history of CRC, inflammatory bowel disease (IBD), or colectomy using International Classification of Disease (9th and 10th edition) diagnostic code or by self-report. The investigators will also exclude veterans with evidence of prior colonoscopy within 10 years, sigmoidoscopy within 5 years, and fecal occult blood test (FOBT)/FIT in the same calendar year. The information used to exclude patients will be derived from the electronic queries or chart audits.
|Official title||Reducing Colorectal Cancer Death Through Mailed Outreach Screening|
|Principal investigator||Emily C. Paulson, MD, MSCE|
|Description||This study seeks to establish the foundation to systematically study and improve the delivery and effectiveness of colorectal cancer (CRC) screening in the VA by developing, implementing and disseminating a pilot mailed-FIT screening outreach program that does not rely on having a clinical office visit. The investigators specifically address the need to identify and remediate potential failures to identify and offer screening to eligible veterans through multilevel interventions. The investigators will also create electronic data linkages to, in future studies, enable evaluation of FIT performance characteristics and help close critical evidence gaps for optimizing screening among veterans. As this is a pilot study, the focus is to assess feasibility of a population-based screening outreach approach through the development, implementation and dissemination of a mailed FIT outreach program in the Philadelphia VA Medical Center that does not rely on having an office visit.|
Call for more information